TRIB Stock Analysis: Buy, Sell, or Hold?
TRIB - Trinity Biotech plc
$0.35
0.01 (3.09%)
▲
5d:
-10.38%
30d:
-46.08%
90d:
-50.98%
WAIT
LOW Confidence
Analysis Updated: Jul 15, 2026 12:00 AM ET
Get Alerted When TRIB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TRIB is down 10.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TRIB is down 10.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TRIB is currently trading at $0.35, which is considered slightly low relative to its 30-day fair value range of $0.34 to $0.61.
Technical Outlook: Technically, TRIB is in a strong uptrend. The price is currently testing key support at $0.62. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.00 (+782.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TRIB is in a strong uptrend. The price is currently testing key support at $0.62. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.00 (+782.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.34 -
$0.61
Company Quality Score
55/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 782.4% below Wall St target ($3.00)
- WARNING: Recommendation downgraded due to -10.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.34 -
$0.61
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.62
Resistance Level
$0.75
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.31
Wall Street Target
$3.00
(+782.4%)
Revenue Growth (YoY)
-5.5%
Earnings Growth (YoY)
-77.3%
Profit Margin
-85.4%
Share & Embed Analysis
Last updated: July 15, 2026 2:11 PM ET
Data refreshes hourly during market hours. Next update: 3:11 PM
Data refreshes hourly during market hours. Next update: 3:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TRIB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 59 HOLD |